Mangold; Susanne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mangold; Susanne.The latest application filed is for "cross-species-specific single domain bispecific single chain antibody".

Company Profile

2.12.19

Mangold; Susanne - Munich DE
MANGOLD; Susanne - Cham CH
Mangold; Susanne - Munchen N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cross-species-specific Single Domain Bispecific Single Chain Antibody App 20220041736 - Kufer; Peter ; et al.	2022-02-10
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20210277143 - KUFER; Peter ; et al.	2021-09-09
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20210269550 - KUFER; Peter ; et al.	2021-09-02
Cross-species-specific single domain bispecific single chain antibody Grant 10,981,998 - Kufer , et al. April 20, 2	2021-04-20
Cross-species-specific Pscaxcd3, Cd19xcd3, C-metxcd3, Endosialinxcd3, Epcamxcd3, Igf-1rxcd3 Or Fapalphaxcd3 Bispecific Single Chain Antibody App 20200362039 - Kufer; Peter ; et al.	2020-11-19
Cross-species-specific Bispecific Binders App 20200095319 - Kufer; Peter ; et al.	2020-03-26
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20190169310 - Kufer; Peter ; et al.	2019-06-06
Pharmaceutical compositions with resistance to soluble CEA Grant 9,982,063 - Lutterbuse , et al. May 29, 2	2018-05-29
Pharmaceutical compositions with resistance to soluble CEA Grant 9,695,250 - Lutterbuse , et al. July 4, 2	2017-07-04
Pharmaceutical Compositions With Resistance To Soluble Cea App 20170137538 - Lutterbuse; Ralf ; et al.	2017-05-18
Cross-species-specific PSMAxCD3 bispecific single chain antibody Grant 9,587,036 - Kufer , et al. March 7, 2	2017-03-07
Cross-species-specific Bispecific Binders App 20160152707 - Kufer; Peter ; et al.	2016-06-02
Pharmaceutical antibody compositions with resistance to soluble CEA Grant 8,901,278 - Rau , et al. December 2, 2	2014-12-02
Human-anti-human cd3 binding molecules Grant 8,784,821 - Kufer , et al. July 22, 2	2014-07-22
Pharmaceutical Compositions With Resistance To Soluble Cea App 20130273050 - LUTTERBUSE; Ralf ; et al.	2013-10-17
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20130129730 - Kufer; Peter ; et al.	2013-05-23
Pharmaceutical compositions with resistance to soluble CEA Grant 8,394,926 - Lutterbuse , et al. March 12, 2	2013-03-12
Cross-species-specific Bispecific Binders App 20120244162 - KUFER; Peter ; et al.	2012-09-27
Pharmaceutical Antibody Compositions With Resistance To Soluble Cea App 20120121600 - RAU; Doris ; et al.	2012-05-17
CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20120034228 - Kufer; Peter ; et al.	2012-02-09
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY App 20110293619 - Kufer; Peter ; et al.	2011-12-01
Cross-species-specific Bispecific Binders App 20100183615 - Kufer; Peter ; et al.	2010-07-22
Cross-species-specific Binding Domain App 20100150918 - Kufer; Peter ; et al.	2010-06-17
Pharmaceutical Compositions With Resistance To Soluble Cea App 20090226432 - Lutterbuse; Ralf ; et al.	2009-09-10
Pharmaceutical Antibody Compositions With Resistance To Soluble Cea App 20090226444 - Rau; Doris ; et al.	2009-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.